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Abstract
Background: In small mammals brown adipose tissue (BAT) plays a predominant role in regulating energy expenditure
(EE) via adaptive thermogenesis. New-born babies require BAT to control their body temperature, however its relevance
in adults has been questioned. Active BAT has recently been observed in adult humans, albeit in much lower relative
quantities than small mammals. Comparing and contrasting the molecular mechanisms controlling BAT growth and
development in mice and humans will increase our understanding or how human BAT is developed and may identify
potential therapeutic targets to increase EE. MicroRNAs are molecular mechanisms involved in mouse BAT development
however, little is known about the miRNA profile in human BAT. The aims of this study were to establish a mouse
BAT-enriched miRNA profile and compare this with miRNAs measured in human BAT. To achieve this we firstly
established a mouse BAT enriched-miRNA profile by comparing miRNAs expressed in mouse BAT, white adipose
tissue and skeletal muscle. Following this the BAT-enriched miRNAs predicted to target genes potentially involved
in growth and development were identified.
Methods: MiRNA levels were measured using PCR-based miRNA arrays. Results were analysed using
ExpressionSuite software with the global mean expression value of all expressed miRNAs in a givensample used
as the normalisation factor. Bio-informatic analyses was used to predict gene targets followed by Ingenuity
Pathway Analysis.
Results: We identified 35 mouse BAT-enriched miRNAs that were predicted to target genes potentially involved
in growth and development. We also identified 145 miRNAs expressed in both mouse and human BAT, of which
25 were enriched in mouse BAT. Of these 25 miRNAs, miR-20a was predicted to target MYF5 and PPARγ, two
important genes involved in brown adipogenesis, as well as BMP2 and BMPR2, genes involved in white adipogenesis.
For the first time, 69 miRNAs were identified in human BAT but absent in mouse BAT, and 181 miRNAs were expressed
in mouse but not in human BAT.
Conclusion: The present study has identified a small sub-set of miRNAs common to both mouse and human BAT.
From this sub-set bioinformatics analysis suggested a potential role of miR-20a in the control of cell fate and this
warrants further investigation. The large number of miRNAs found only in mouse BAT or only in human BAT highlights
the differing molecular profile between species that is likely to influence the functional role of BAT across species.
Nevertheless the BAT-enriched miRNA profiles established in the present study suggest targets to investigate in the
control BAT development and EE.
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Background
Obesity is a world-wide epidemic that increases the risk
of cardiovascular disorders, cancer and type 2 diabetes
(T2D) [1]. Obesity results from an energy imbalance
whereby energy intake (EI) exceeds energy expenditure
(EE). Strategies to decrease obesity have been orientated
towards a reduction in EI, unfortunately without success
[2]. Consequently, new therapeutic strategies aimed at
targeting EE are being investigated. Discovery of active
human brown adipose tissue (BAT) has renewed interest
in the possibility that it may regulate metabolism and EE
in humans [3–5].
Skeletal muscle is another tissue that plays an import-
ant role in regulating EE and several lines of evidence
suggest that skeletal muscle and BAT share a common
lineage [6, 7]. microRNAs (miRNAs) are short non-
coding RNAs that regulate gene expression and tissue
development [8, 9]. Muscle-enriched microRNAs includ-
ing miR-1, −133a and −206, are also expressed in murine
brown pre and mature adipocytes, but not in white adi-
pocytes [10]. The PRD1-BF-1-RIZ1 homologous domain
protein containing protein-16 (PRDM16), a BAT-enriched
protein controls the differentiation between BAT and skel-
etal muscle by forming a transcriptional complex with
CCAAT/Enhancer binding protein β (C/EBPβ) [11–13].
Understanding the mechanisms controling BAT differenti-
ation may identify potential therapeutic targets to enhance
BAT-controlled metabolism and to increase EE.
MiRNA screenings and bioinformatics analyses have
identified potential gene targets and biological functions
controlled by certain miRNAs in tissues and diseases.
Sun et al. observed 91 differentially expressed miRNAs
when comparing mouse BAT, white adipose tissue (WAT)
and skeletal muscle [14]. The oligonucleotide microchip
technology used in this study allowed for the screening of
only ~350 miRNAs however is not as sensitive as quanti-
tative real time-polymerase chain reaction (RT-PCR) array
technology [15]. Investigation of a broader number of
BAT miRNA targets using highly sensitive qPCR-array
methods will provide a more comprehensive overview of
the potential miRNAs regulating BAT development and
function. Several miRNAs controlling mouse brown adi-
pocyte development and function have been identified in
mice, including miR-27, −34a, −133, −155, −182, −193b-
365, −196, −203 and miR-378 [14, 16–23]. MiR-27 is de-
creased in mouse BAT following cold exposure and during
brown adipogenesis [22]. As a consequence, several of
the miR-27 target genes, including Prdm16, peroxisome
proliferator-activated receptor alpha (Pparα), cAMP re-
sponse element-binding protein (Creb) and peroxisome
proliferator-activated receptor gamma coactivator 1-beta
(Pgc1β) are upregulated, and enhance brown adipogenesis.
MiR-34a inhibits beige and brown fat formation by target-
ing fibroblast growth factor-21 (Fgf21) and sirtuin 1
(Sirt1), two known activators of WAT browning [20].
miR-133 directly targets the 3’-UTR of Prdm16 [19] and
controls the differentiation of satellite cells within skeletal
muscle towards an adipogenic or myogenic phenotype
[17, 19]. While the cluster miR-193–365 is up-regulated
by Prdm16, partially through Pparγ [14], they are not
required for brown fat development and function [24].
MiR-182 and miR-203 are BAT-specific miRNAs, essential
for the maintenance and differentiation of brown adipo-
cytes in vivo [21]. Finally, miR-378 increases brown fat
mass and as a consequence, suppresses development of
beige adipocytes in subcutaneous WAT [23]. However it is
unknown if these miRNAs are expressed in human BAT.
BAT plays a critical role in the regulation of energy
balance and temperature in rodents and newborns [25–27],
however its role in human adult metabolism remains
equivocal. While mice still remain the investigative of
model of choice to understand the role and regulation
BAT, studies establishing the similarities and differences
in the molecular profile of mouse and human BAT are
required.
Therefore the primary aims of this study were to (1)
identify BAT-enriched miRNAs by comparing miRNA
expression mouse BAT, skeletal muscle and WAT using
PCR-based miRNA arrays (2); predict the BAT-enriched
miRNA target genes potentially involved in growth,
proliferation and development; (3) compare the miRNA
profiles of mouse and human BAT.
Results
Mouse BAT, WAT and skeletal muscle tissues
miRNA array analysis on mouse tissues
To define miRNAs enriched in mouse BAT, comparisons
were made between BAT, skeletal muscle (gastrocnemius)
and WAT as described in the flowchart (Fig. 1). From the
750 miRNAs profiled 433 miRNAs were expressed at least
in one tissue. The Venn diagram represents the tissue
distribution of these 433 miRNAs. Six miRNAs were
exclusively expressed in BAT. Nineteen miRNAs (circled)
were expressed only in BAT and WAT, with four of these
significantly higher in BAT tissue (p < 0.05). Three miRNAs
were expressed only in BAT and muscle and at similar
levels. There were 298 miRNAs (circled) commonly
expressed in the three tissues, of which 54 were sig-
nificantly higher in BAT compared to WAT and muscle
(p < 0.05). When adding all the exclusively and highly
expressed miRNAs found in BAT, 64 BAT-enriched
miRNAs were obtained as shown in the heat map below
(Fig. 2).
Eleven miRNAs were exclusively expressed in muscle,
67 miRNAs were exclusively expressed in WAT, while
another 29 of miRNAs were expressed in both muscle
and WAT only (Additional file 1). A more detailed explan-
ation of this analysis can be found in Additional file 2.
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Bio-informatic analyses on mouse BAT-enriched miRNAs
To identify miRNAs potentially involved in BAT develop-
ment a microRNA target filter was performed using IPA
software (Ingenuity®Systems, www.ingenuity.com). Of the
64 BAT-enriched miRNAs, 35 miRNAs were predicted to
target 859 genes potentially involved in cellular growth,
proliferation and development (Additional file 3). Table 1
presents these 35 miRNAs as well as the number of
predicted genes targeted by each miRNA. miR-15a was
predicted to target the most genes involved in cellular
growth, proliferation and development pathways.
Comparison of miRNA expressed in human and mouse BAT
To establish if human and mouse BAT express similar
BAT-enriched miRNAs, miRNA array analysis was per-
formed on 5 human and 4 mouse BAT samples. Data were
analysed as described in the flowchart (Fig. 3). Of the 750
miRNAs measured 214 miRNAs and 326 miRNAs were
expressed in a minimum of 3 human BAT samples and
3 mouse BAT samples, respectively. Of these miRNAs,
145 were expressed in both human and mouse BAT
(Additional file 4), including 23 miRNAs that had the
same name but their sequences differed by few nucleo-
tides between the species (i.e. miR-155, miR-193b, miR-
455). Therefore, 69 miRNAs were expressed in human
BAT but not mouse BAT, while 181 miRNAs were
expressed in mouse BAT but not human BAT.
As shown in the flowchart in Fig. 4 a comparison was
made between the 145 miRNAs common to both human
and mouse BAT and with the 35 mouse BAT-enriched
miRNAs identified from the bio-informatic analyses in
Table 2. Twenty five of the 35 mouse BAT-enriched
miRNAs were also expressed in human BAT and were
predicted to regulate 788 genes involved growth, pro-
liferation and development pathways (Additional file
5). Ten miRNAs enriched in mouse BAT were not
expressed in human BAT. Of the 25 BAT-enriched miRNAs
commonly expressed in human and mouse BAT, 10 had
previously been predicted to target gene involved in brown
adipogenesis. These 10 miRNAs and their predicted regula-
tory network are presented in Fig. 5. Bone morphogenetic
protein 2 (BMP2) and BMP7 are predicted to be targeted by
miR-20a,-140 and miR-25, −30b, respectively. Bone morpho-
genetic protein receptor 2 (BMPR2) is known to be targeted
by miR-19a, −20a and miR-25 [28] and predicted to be
targeted by miR-455. Homeobox C9 (HOXC9) is predicted
to be targeted by miR-193, 150 and -26b. Finally, PPARγ is
known to be targeted by miR-20a [29] and myogenic factor
5 (MYF5) is predicted to be targeted by miR-20a.
Discussion
The recent discovery of active BAT in human adults
[30–35] has opened a new field of investigation for the
treatment of obesity [3–5]. Therefore, understanding the
Fig. 1 Flow chart of the miRNA array analysis from mouse tissues
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molecular mechanisms, regulating human BAT develop-
ment may identify novel therapeutic strategies to increase
energy expenditure. miRNAs are important molecular
switches that display high levels of tissue enrichment and
can control cell differentiation and tissue growth and de-
velopment. Studies have investigated miRNAs in mouse
BAT [10, 14, 16–24], however their expression levels have
not been validated in human BAT. The present study
measured and compared the expression of miRNAs highly
enriched in mouse and human BAT, as well as predicting
their gene targets potentially involved in BAT growth
and development. Several novel observations were made.
Firstly, 64 miRNAs were exclusively or highly expressed in
mouse BAT in comparison to mouse skeletal muscle and
WAT. Secondly, of these 64 BAT-enriched miRNAs, 35
were predicted to regulate genes involved in cellular
growth, proliferation and development. Thirdly, 145
miRNAs were found to be commonly expressed in human
and mouse BAT. Finally, 25 of these 145 miRNAs were
also identified in the list of 35 mouse BAT-enriched
miRNAs potentially involved in cellular growth, prolif-
eration and development.
Identifying the molecular mechanisms (i.e. miRNAs)
controlling BAT development has become a priority to
develop therapeutic strategies in the fight against obesity.
While BAT shares a common origin with skeletal muscle
[6, 7], studies in mouse WAT recently discovered a
phenomenon called “browning” that involves the forma-
tion of brown adipocytes in WAT after cold exposure or
β-adrenergic stimulation [36]. Therefore, it was of interest
to compare these three mouse tissues in order to iden-
tify BAT-enriched miRNAs. In the present study, qPCR-
based miRNA screening of ~750 miRNAs identified 64
miRNAs exclusively or highly expressed in mouse BAT, in
comparison to skeletal muscle and WAT. Consistent with
a similar study [14], we identified that ~22% of the
miRNAs commonly expressed between the three tissues
were significantly higher in BAT. Of the 64 miRNAs
Fig. 2 Heat map of the 64 miRNAs specifically and highly expressed in mouse BAT as compared with muscle and WAT. Values 1 and 12 represent the
lowest and highest values, respectively. White values represent non-expressed miRNAs
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observed to be enriched in mouse BAT in the present
study, only 15 have previously in BAT [14].
miRNAs regulate various component of cellular net-
works and maintain cellular homeostasis [37]. Therefore
it was of interest to select BAT-enriched miRNAs that
were predicted to target genes specifically involved in
cellular growth, proliferation and development and as
such may also control BAT development. Thirty-five of
the 64 miRNAs were predicted to target 859 genes in-
volved in growth and development pathways. In cultured
adipocytes, global deep sequencing identified 16 and 12
miRNAs that were differentially regulated in mouse pri-
mary pre-adipocytes when compared with differentiated
mature brown adipocytes in vitro, [18]. Of the miRNAs
upregulated in differentiated mature brown adipocytes,
miR-142-3p and -19a were also up-regulated in the
present list of 35 BAT-enriched miRNAs predicted to
target genes involved in growth and differentiation. This
supports a potential role of these miRNAs during BAT
development in mice. While miR-155 and −328 were
down-regulated in mature brown adipocytes when com-
pared to pre-adipocytes, they were identified as being
upregulated in our list of 35 BAT-enriched miRNAs.
These discrepancies may be indicative of the differences
between mature brown adipocytes in vitro and mature
BAT.
Table 1 Highly expressed miRNAs in mouse BAT. Number of targets predicted to regulate growth, proliferation and development.
Relative expression values are arbitrary units (A.U.) and have been calculated relative to mouse miR-15a
miRNA Number of targeted mRNAs Relative expression (A.U) miRNA Number of targeted mRNAs Relative expression (A.U.)
miR-15a 184 1.0 miR-140 48 2.7
miR-20a 149 8.1 miR-150 45 69.4
miR-19a 141 1.5 miR-193 39 0.4
miR-30b 139 239.2 miR-328 39 5.06
miR-182 135 1.8 miR-542-3p 39 0.004
let-7g 133 7.9 miR-491 38 0.07
miR-203 112 9.1 miR-18a 37 0.05
miR-351 108 0.0 miR-455 33 0.54
miR-26b 106 3.8 miR-484 11 17.6
miR-25 100 0.6 miR-451 10 1.10
miR-320 97 2.0 miR-129-3p 9 0.1
miR-107 92 0.6 miR-126-3p 6 337.2
miR-374-5p 89 3.8 miR-450a-5p 3 0.0
miR-155 82 0.6 miR-671-3p 3 0.1
miR-132 75 1.2 miR-345-3p 2 0.1
miR-423-5p 58 0.1 miR-582-3p 2 0.0
miR-142-3p 55 2.1 miR-338-5P 1 0.2
miR-365 49 67.1
Fig. 3 Flow chart of the miRNA array analysis for the comparisons of human and mouse BAT
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Most studies have used mice as a model to study BAT
development and function, due to the previously held
view that adult humans did not possess BAT, as well as
the limited access to human BAT from new born babies.
As such, no study has looked at the miRNA profile of
human BAT. It was therefore of interest to compare
miRNA profiles of mouse and human BAT to establish
the potential molecular similarities and differences be-
tween the two species. These comparisons also provide a
snapshot of the potential to translate molecular observa-
tions from mice to humans. For the first time, a miRNA
screening revealed the presence of 214 miRNAs expressed
in human BAT, including 145 commonly expressed in
mouse BAT. This screening also showed that 69 miRNAs
expressed in human BAT were not expressed in mouse
BAT and therefore were not taken into consideration
when comparisons were made with the mouse model.
Further investigations of these 69 miRNAs will be re-
quired to identify their potential unique role in human
BAT development and function. In contrast, 181 miRNAs
in mouse BAT were not present in human BAT, suggest-
ing that translating results from mouse to human BAT
needs careful consideration.
Of the 145 miRNAs common to both mouse and hu-
man BAT, 25 were identified in the list of 35 mouse
BAT-enriched miRNAs potentially targeting genes in-
volved in cellular growth, proliferation and development.
788 genes involved in these pathways were predicted to
be targeted by these 25 miRNAs. In this present study,
miR-20a was the only miRNA predicted to target MYF5
and PPARγ (a previously experimentally observed target
[38]), two important factors directing cell fate towards a
brown fat phenotype [11]. In contrast, miR-20a is also
predicted to target BMP2 and BMPR2, a growth factor
and receptor increased in white fat differentiation [39].
These findings suggest that miR-20a may have the cap-
acity to control cell fate toward a brown or white fat
phenotype. Furthermore, miR-20a was the miRNA
targeting the second most numbers of genes (n = 149)
involved in growth and development, highlighting its
Fig. 4 Flow chart of the miRNA analysis for the comparisons between human and mouse BAT-enriched miRNAs
Table 2 miRNA expression in both human and mouse BAT. Number of targets predicted to regulate growth, proliferation and
development. Relative expression values are arbitrary units (A.U.) and have been calculated relative to human miR-15a
miRNA Number of targeted mRNAs Relative expression (A.U) miRNA Number of targeted mRNAs Relative expression (A.U)
miR-15a 184 1.0 miR-365 49 9.2
miR-20a 149 13.2 miR-140 48 7.2
miR-19a 141 12.7 miR-150 45 101.4
miR-30b 139 26.2 miR-193 39 6.8
let-7g 133 15.1 miR-328 39 0.4
miR-203 112 0.3 miR-491 38 0.5
miR-26b 106 15.5 miR-18a 37 0.2
miR-25 100 0.3 miR-455 33 0.4
miR-320 97 44.3 miR-484 11 65.6
miR-155 82 4.6 miR-451 10 1.9
miR-132 75 6.8 miR-126-3p 6 1438.0
miR-423-5p 58 0.4 miR-338-5P 1 1160.2
miR-142-3p 55 2.7
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potential importance in these pathways. To date, miR-20a
has not been studied in relation to BAT growth and devel-
opment and therefore requires further investigation.
miR-155, highly expressed in brown pre- adipocytes
when compared to differentiated mature brown adipocytes,
inhibits brown adipogenesis by targeting C/EBPβ [18], a
transcription factor forming a complex with PRDM16 dur-
ing brown adipogenesis [13]. In contrast to these observa-
tions, miR-155 was identified as a highly enriched miRNA
in human and mouse BAT. This observation suggests that
Fig. 5 Selected miRNAs common to human and mouse BAT and their gene targets known to be involved in brown adipogenesis
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human BAT may be comprised of a mixed composition of
cells with different stages of cell maturation. However, the
presence of miR-20a, −25 and -30b, all predicted to inhibit
expression of genes involved in brown fat develop-
ment, may prevent the development of a “classical”
brown fat phenotype in human BAT. Furthermore,
miR-182 and −203 were also part of the top ten miRNAs
targeting the most genes involved in growth and develop-
ment in mouse BAT, suggesting their potentials roles in
brown adipocyte development [21]. However, only
miR-203 was conserved in human BAT. The absence
of miR-182 expression in human BAT might contribute to
differences between mouse and human BAT development
and function. A gene signature developed in human BAT
identified a profile closely resembling a brite/beige pheno-
type [40, 41]. This phenotype is supported by the absence
of miR-378, a key regulator controlling classical BAT-
specific expansion and obesity resistance [23]. However
the phenotypical signature may depend on the depth of
the tissue taken with superficial tissue representing a more
WAT-like signature while deeper tissue representing a
more classical BAT-like signature [42].
The miR-193b-365 cluster and miR-455 are known to
regulate mouse brown fat development and were iden-
tified in our selection of 25 BAT-enriched miRNAs
common to mice and humans. Inhibition of miR-193a/b
and/or miR-365 in mouse primary brown pre-adipocytes
impairs brown adipogenesis in vitro [14]. However,
miR-193b null mice, that are also deficient in miR-365,
have normal BAT development, differentiation and func-
tion [24]. miR-193b null mice have elevated levels of
miR-455 suggesting a compensatory effect in the absence
of the miR-193b-365 cluster. miR-455 expression levels
are also increased in mature murine brown adipocytes
and positively correlate with uncoupling protein 1 (UCP1)
levels suggesting a potential metabolic role in brown
adipocytes [10]. miR-19a, −140, −150 and -26b are predicted
to target white fat-related genes (BMP2 or BMPR2 or
HOXC9) [39, 41] and therefore may have a role in
selecting cell fate toward brown adipogenesis.
In the present study BAT from newborns was used to
establish the human BAT miRNA profile. How precisely
these findings translate to the human adult is presently
unknown. Human newborns and adults have a similar
distribution of BAT depots [43]. In newborns and infants
BAT is mostly located in the interscapular, cervical and
perirenal regions [43, 44]. In human adults the major de-
pots of metabolically active BAT have been identified in
the cervical, supraclavicular, axillary and paravertebral re-
gions [30, 32, 33]. The location and quantity of human
BAT alters with age, which may indicate an age-dependent
change in its primary role; presently the precise functional
role of adult BAT is yet to be determined. However, when
the hands of both infants and adults are cooled there is a
0.3-0.7°C increase in subcutaneous cervical BAT, albeit to
a lesser degree in older subjects [45]. This suggests that
both infant and adult BAT may respond in a similar way
to some external stress signals. Several studies have tried
to develop a mRNA profile to establish how similarly in-
fant and adult human BAT [40, 42] and brown adipocytes
[44, 46] mimic the “classical” rodent BAT on a molecular
level. Depending on the depth and location of the tissue
analysed, infant and adult human BAT possess gene signa-
tures with a mixture of “classical” BAT and “beige-like”
adipocytes. The present study analysed newborn BAT
taken from regions where active BAT is also found in
the human adult. Therefore, it is most likely that the
newborn human BAT miRNA profile established here
would represent an adult profile with a mixture of
“classic” BAT and/or “beige-like” adipocytes. Investiga-
tions are still required to clearly identify the mRNA
and the miRNA species that are truly specific to brown
and beige tissue; a task that that may complicated by
the different levels of heterogeneity within BAT tissue
depots.
Conclusion
This study has identified 64 miRNAs enriched in mouse
BAT when compared to skeletal muscle and WAT, includ-
ing 35 miRNAs specifically involved in cellular growth,
proliferation and development. Furthermore, for the first
time a comparison between human and mouse BAT re-
vealed the presence of 145 commonly expressed miRNAs
in BAT from both species. These included 25 miRNAs
specifically expressed in mouse BAT and involved in cellu-
lar growth, proliferation and development. The identifica-
tion of BAT-enriched miRNAs, conserved in both mouse
and human BAT, such as miR-20a, may be a common
factor controlling BAT development. Several of the newly
identified miRNAs, common to mouse and human
BAT, should be evaluated for their direct role in brown
adipogenesis.
Methods
Tissue collection
The interscapular BAT, gastrocnemius and visceral WAT
from 8 week old male C57BL/6J mice were donated by
Professor Matthew Watt, Monash University. The tissue
provided was approved by the School of Biomedical
Sciences Animal Ethics Committee (SOBSA/2009/22)
Monash University, Australia. RNA samples from human
BAT, obtained from newborn humans aged between
10.6 ± 4.3 days, were donated by Professor Vicente Gilsanz
from the Children’s Hospital Los Angeles (CHLA), USA.
The RNA samples were originally obtained as a compo-
nent of a previously published study [40]. This previously
published human study was approved by the Institutional
Review Board of the CHLA (CCI-10-00073). The Deakin
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University Human Research Ethics Committee Executive
also reviewed the project (CCI-10-00073) and acknowl-
edged the approval granted by the Institutional Review
Board of the CHLA and allocated the project reference
number 2015–189. Written informed consent was ob-
tained by all parent/legal guardian(s) in the presence of
a witness authorizing post-mortem examination and re-
moval of tissues. Authorization was also given for the
samples to be retained and preserved and to be used
for diagnostic, therapeutic and other scientific purposes
as deemed appropriate by the examining physician or
surgeon. The research was carried out on in compliance
with the Helsinki Declaration. The samples were surgi-
cally removed from the subcutaneous supraclavicular/
supracervical area, intra-abdominal area or retroperi-
toneal area during post-mortem examination 24h after
death and have been used previously of mRNA measure-
ments [40]. miRNAs are exceptionally stable post-mortem
[47] and therefore the miRNA profile generated would be
representative of that observed in a living human. All
tissue samples were snapped frozen in liquid nitrogen
and kept at −80°C until required for RNA extraction.
RNA extractions
Mouse tissues
Approximately 20 mg of BAT and gastrocnemius and
100 mg of WAT were homogenised in 500 μl of Tri-
Reagent® Solution (Life Technologies, CA, USA), using
the MagNA Lyser (Roche, Basel, Switzerland) for 20s at
a speed setting of 5500 revolutions per minute (rpm).
After transferring the homogenate into a fresh tube, RNA
extraction was completed according to the manufac-
turer’s protocol. Quality of the RNA was assessed using
a Nanodrop 1000 Spectrophotometer (Thermo Fisher
Scientific, MA, USA) and only samples with an O.D.
260/280 ratio >1.9 were used for the analyses.
Human tissues
Approximately 20 mg of BAT were homogenised in 300 μl
of the denaturation solution from the TōTALLY RNA kit™
(Life Technologies, CA, USA), using the MagNA Lyser
(Roche, Basel, Switzerland) for 20s at a speed setting of
5500rpm. After transferring the homogenate into a fresh
tube, RNA extraction was completed according to the
manufacturer’s protocol. Quality of the RNA was assessed
using a Nanodrop 1000 Spectrophotometer (Thermo
Fisher Scientific, MA, USA) and only samples with an
O.D. 260/280 ratio >1.9 were used for the analyses.
Megaplex reverse transcription and miRNA arrays
Mouse and human tissues
Rodent Megaplex™ Primer Pools and TaqMan® Array
miRNA Cards A version 2.0 and B version 3.0 (Life
Technologies, CA, USA) were used to reverse transcribe
and amplify ~750 miRNAs according to the manufac-
turer’s protocol. This was performed on 4 BAT, 4 gastro-
cnemius and 4 WAT samples. Human Megaplex™ Primer
Pools and TaqMan® Array miRNA Cards A version 2.1
and B version 3.0 (Life Technologies, CA, USA) were used
to reverse transcribe and amplify ~750 miRNAs according
to the manufacturer’s protocol. This was performed on
human tissues from 5 different individuals. All cards were
run on the 7900HT Fast Real-Time PCR System machine
at Monash Institute of Medical Research (MIMR, Clayton,
VIC, Australia). Results were analysed using Expres-
sionSuite software v1.0.1 (Life Technologies, CA, USA).
The global mean expression value of all expressed miRNAs
in a given samples was used as the normalisation factor in
this study [48].
Bio-informatics
Bio-informatic analyses were performed on specific lists of
miRNAs to determine their predicted gene targets. Data
were analysed through the use of IPA (Ingenuity®Systems,
www.ingenuity.com) and more specifically, the microRNA
Target filter tool. Filters were used to refine the analysis
based on experimentally observed and high predicted gene
targets only in the column “confidence”, as well as gene
involved in cellular growth, proliferation and development
pathways only.
Statistics
For the mouse samples, miRNAs were considered expressed
in a given tissue when a minimum of 3 out of the 4 samples
analysed had CT values below 32, as suggested in the manu-
facturer’s protocol. miRNAs expressed in 2 tissues only were
compared using an unpaired t-test following log transform-
ation of their expression values. For the miRNAs expressed
in the 3 tissues (BAT, gastrocnemius and WAT), statistical
analysis was performed using STATA data analysis and
statistical software using a Kruskal–Wallis test. When a
significant difference was detected a two-sample Wilcoxon-
rank sum test was used to locate the differences. A p-value
of <0.05 was considered as significant for all analyses.
For the human samples, miRNAs were considered
expressed in a given tissue when a minimum of 3 samples
(out of 5) had CT values below 32, as mentioned in the
manufacturer’s protocol.
Availability of supporting data
The data sets supporting the results of this article are
included within the articles (and its additional files).
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tissues. (PDF 539 kb)
Additional file 3: Table of the 35 mouse BAT-enriched miRNAs and
their predicted gene targets involved in cellular growth, proliferation
and differentiation. (PDF 447 kb)
Additional file 4: Table of the 145 miRNAs commonly expressed in
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Additional file 5: Table of the 25 mouse BAT-enriched miRNAs in
human BAT and their predicted gene targets involved in cellular
growth, proliferation and differentiation. (PDF 429 kb)
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